In children with MRSA pneumonia, miR-155 has been associated with a Th9/IL-9 response, and targeting of miR-155 was suggested to be a potential new strategy to treat MRSA (71). Here, IL9 is linked to Methicillin-Resistant Staphylococcus Aureus Pneumonia.